Results 111 to 120 of about 4,164 (194)

The Effects of Switch Therapy in Osteoporosis Treatment after Romosozumab after Comparing with Prior Treatment

Journal of Osteoporosis
Rationale. Although romosozumab is one of the most effective treatments for osteoporosis by increasing bone mineral density in the lumbar spine and femur and recommended for denosumab as switch therapy, these effects regarding its prior treatment have ...
Akira Horikawa, Yuji Kasukawa, Michio Hongo, Akihisa Sano, Naohisa Miyakoshi   +4 more
doaj   +1 more source

Effects of romosozumab combined with routine therapy on pain relief, disease progression and adverse reactions in patients with postmenopausal osteoporosis: a systematic review and meta-analysis

Frontiers in Medicine
BackgroundPostmenopausal osteoporosis (PMOP) increases fracture risk in women. Though traditional treatments are slow to act, combining romosozumab with conventional therapy shows promise.
Ge Gao, Jian Cui, Yuanyuan Xie, Jing Dong   +3 more
doaj   +1 more source

Sclerostin antibody treatment enhances rotator cuff tendon-to-bone healing in an animal model [PDF]

, 2017
Alfredson, Black, Bone, Cadet, Chouinard, Colvin, Ditsios, Galatz, Galatz, Galatz, Genin, Gimbel, Ide, Ioannis Kormpakis, Keener, Kennel, Killian, Killian, Komori, Leesa M. Galatz, Leppälä, Li, Li, Li, Lipner, Manning, McClung, Michael S. Ominsky, Nakashima, Necat Havlioglu, Ominsky, Padhi, Schwartz, Schwartz, Shivam A. Shah, Silva, Sinder, Stavros Thomopoulos, Taylor, Thomopoulos, Thomopoulos, Thomopoulos, Thomopoulos, Tian, Veverka, West   +45 more
core   +3 more sources

Examining Romosozumab Adherence and Side Effects in Osteoporotic Patients After Surgical Fracture Fixation: A Comparative, Descriptive, and Hypothesis-Generating Study with Non-Fractured Controls

Diseases
Objectives: The study aims to evaluate adherence to Romosozumab treatment in osteoporotic patients after surgical fracture fixation and compare side effects with non-fractured controls on the same therapy.
Amarildo Smakaj, Umberto Tarantino, Riccardo Iundusi, Angela Chiavoghilefu, Lorenzo Abbondante, Chiara Salvati, Chiara Greggi, Elena Gasbarra   +7 more
doaj   +1 more source

Role of Anabolic Anti-Osteoporosis Therapy in Diabetes Subjects

Indian Journal of Endocrinology and Metabolism
Diabetes mellitus (DM) is a metabolic disorder that leads to the destruction of various tissues including bones. The pathogenesis of osteoporosis (OP) varies in DM due to many specific factors.
Harsh Durgia, Rajan Palui, Jayaprakash Sahoo, Sadishkumar Kamalanathan, Dukhabandhu Naik   +4 more
doaj   +1 more source

Pharmacological Therapy of Osteoporosis: What’s New?

Clinical Interventions in Aging, 2020
Giovanni Iolascon,1 Antimo Moretti,1 Giuseppe Toro,1 Francesca Gimigliano,2 Sara Liguori,1 Marco Paoletta1 1Department of Medical and Surgical Specialties and Dentistry, University of Campania “Luigi Vanvitelli”, Naples, Italy; 2Department of
Iolascon G, Moretti A, Toro G, Gimigliano F, Liguori S, Paoletta M   +5 more
doaj  

Medical Management of Osteoporosis: Updates and Future Directions

Indian Spine Journal
Osteoporosis, characterized by deterioration of bone microarchitecture, increased bone fragility, and subsequent low-trauma fractures, is the most prevalent bone disease in human beings.
Aasim N. Maldar, Manoj Chadha
doaj   +1 more source

Inducible expression of Wnt7b promotes bone formation in aged mice and enhances fracture healing [PDF]

, 2020
He, Guangxu, Liao, Lele, Liu, Xiaochen, Long, Fanxin, Ni, Jiangdong, Silva, Matthew J., Song, Deye, Song, Fangfang, Wang, Zhepeng   +8 more
core   +1 more source

Romosozumab Efficacy in Osteoporosis: Influence of Diabetes and Previous Antiresorptive Therapy: A Single Centre Experience. [PDF]

Clin Med Insights Endocrinol Diabetes
Alshamsi H, Alnaqbi D, Sharma C, Govender RD, Almazrouei R.   +4 more
europepmc   +1 more source

Comparative Radiologic Outcomes of Romosozumab and Teriparatide in Osteoporotic Vertebral Fractures. [PDF]

J Clin Med
Lee JS, Kim GU, Jung HY, Kim YH, Kim SI, Park S, Kim YY, Park HY.   +7 more
europepmc   +1 more source